Galen buys Bristol-Myers Squibb's Estrace tabs
Executive Summary
Galen Holdings (branded prescription pharmaceuticals) acquired from Bristol-Myers Squibb the tablet formulation of its branded estrogen replacement therapy, Estrace (estradiol), for $95mm (UK67.2mm) in cash.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
- Product Purchase
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice